Login

Antony Mattessich, President & CEO, Ocular Therapeutix 00:00:00

Share On Facebook Share On Twitter

Ocular Therapeutix

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Medicure, Inc MCUJF CEO Albert Friesen on 2020 Results - Albert D. Friesen, PhD. Chief Executive Officer and Chairman of the Board, Medicure Inc
00:10:00
Mastering Investor Psychology with Fyooz Financial Planning | Dan Slagle, Founding Partner and Financial Planner of Fyooz Financial Planning
00:10:00
Venture capital firm that invests in start-ups that apply data and technology to disrupt existing industries|David Waxman,Managing Partner,TenOneTen Ventures
00:10:00
Avoiding a Big Tax Surprise: Year-Round Tax Planning Strategies | Joel Cundick - Financial Advisor, Savant Wealth Management
00:10:00
Connecting Canadian and Aboriginal Businesses for Economic Success
00:00:00
Dr. Scott Cheney talks about benign prostatic hyperplasia - Scott M. Cheney, M.D.
00:10:00
Phunware Inc. Chief Operating Officer Randall Crowder shares news of the company licensing its technology with Proactive's Stephen Gunnion..|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
Meet Wayne Johnson: Syverson Strege Team Interview | Wayne Johnson - Financial Planner of Syverson Strege
00:10:00
Focus on B2B Saas and Fintech across Europe|Julia Andre,Partner,Index Ventures
00:10:00
Benoist Grossmann Discusses IDInvest's Venture Capital Strategy and Early Career Influences | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:10:00
Candles Scandinavia CEO Viktor Garmiani Discusses Q1 Performance: Tackling Disruptions and Optimizing Production | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Macquarie Group's Fiscal Year 2024 Performance and Strategic Overview | Shemara Wikramanayake , CEO , Macquarie Asset Management .

© 2017 - Neuhu+